Relmada Therapeutics, Inc. (RLMD) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 235.34M | 93.98M | 14.85M | 21.09M | 27.66M | 45.8M | 55.7M | 70.97M | 84.37M | 97.51M | 109.1M | 122M |
| Cash & Short-Term Investments | 233.96M | 93.01M | 13.89M | 20.62M | 27.06M | 44.91M | 54.12M | 70.44M | 83.61M | 96.32M | 106.27M | 118.53M |
| Cash Only | 9.78M | 3.5M | 1.38M | 1.35M | 1.15M | 3.86M | 1.48M | 2.09M | 1.34M | 4.09M | 6.7M | 14.47M |
| Short-Term Investments | 224.19M | 89.51M | 12.5M | 19.27M | 25.91M | 41.05M | 52.63M | 68.35M | 82.28M | 92.23M | 99.57M | 104.06M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.38M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37 | 0 |
| Total Non-Current Assets | 19.5K | 19.5K | 21.97K | 21.98K | 21.98K | 21.98K | 21.98K | 53.63K | 43.13K | 43.13K | 47.72K | 34.59K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 19.5K | 19.5K | 21.97K | 21.98K | 21.98K | 21.98K | 21.98K | 53.63K | 43.13K | 43.13K | 47.72K | 34.59K |
| Total Assets | 235.36M | 94M | 14.88M | 21.12M | 27.68M | 45.82M | 55.72M | 71.03M | 84.41M | 97.55M | 109.15M | 122.04M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 750.32% | 105.17% | -73.3% | -70.27% | -67.21% | -53.03% | -48.95% | -41.8% | -37.74% | -36.2% | -41.67% | -43.44% |
| Total Current Liabilities | 12.89M | 6.43M | 5.19M | 5.13M | 5.23M | 10.29M | 8.09M | 9.54M | 12.36M | 12.19M | 8.42M | 10.7M |
| Accounts Payable | 5.73M | 1.57M | 1.45M | 1.36M | 1.27M | 4.13M | 2.35M | 4.17M | 5.19M | 3.51M | 2.86M | 4.85M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 7.16M | 4.86M | 1.82M | 2.23M | 1.02M | 1.15M | 5.74M | 1.02M | 0 | 5.68M | 1.46M | 0 |
| Current Ratio | 18.26x | 14.62x | 2.86x | 4.11x | 5.29x | 4.45x | 6.89x | 7.44x | 6.82x | 8.00x | 12.95x | 11.40x |
| Quick Ratio | 18.26x | 14.62x | 2.86x | 4.11x | 5.29x | 4.45x | 6.89x | 7.44x | 6.82x | 8.00x | 12.95x | 11.40x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 3.74M | 1.06M | 221.11K | 32.12K | 7.5K | 4.47K | 12.56K | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 3.74M | 1.06M | 221.11K | 32.12K | 7.5K | 4.47K | 12.56K | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 16.63M | 7.49M | 5.41M | 5.17M | 5.24M | 10.3M | 8.1M | 9.54M | 12.36M | 12.19M | 8.42M | 10.7M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -9.78M | -3.5M | -1.38M | -1.35M | -1.15M | -3.86M | -1.48M | -2.09M | -1.34M | -4.09M | -6.7M | -14.47M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 218.73M | 86.51M | 9.47M | 15.95M | 22.44M | 35.52M | 47.63M | 61.49M | 72.05M | 85.36M | 100.73M | 111.34M |
| Equity Growth % | 874.72% | 143.55% | -80.12% | -74.06% | -68.85% | -58.38% | -52.72% | -44.77% | -42.58% | -39.22% | -39.45% | -43.44% |
| Book Value per Share | 2.53 | 1.27 | 0.29 | 0.48 | 0.74 | 1.18 | 1.58 | 2.04 | 2.39 | 2.84 | 3.35 | 3.70 |
| Total Shareholders' Equity | 218.73M | 86.51M | 9.47M | 15.95M | 22.44M | 35.52M | 47.63M | 61.49M | 72.05M | 85.36M | 100.73M | 111.34M |
| Common Stock | 104.89K | 73.33K | 33.19K | 33.19K | 33.19K | 30.17K | 30.17K | 30.17K | 30.17K | 30.1K | 30.1K | 30.1K |
| Retained Earnings | -717.32M | -698.27M | -678.4M | -668.31M | -658.44M | -640.88M | -622.22M | -600.5M | -582.73M | -560.9M | -535.74M | -513.74M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |